|
시장보고서
상품코드
2152352
첨단 안과 의료 기술 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 용도별, 지역별 및 부문별 전망(2026-2033년)Advanced Ophthalmology Technology Market Size, Share & Trends Analysis Report By Type (Diagnostic, Therapeutic), By End Use (Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics), By Region, And Segment Forecasts, 2026 - 2033 |
||||||
세계 첨단 안과 기술 시장 규모는 2025년 91억 달러로 평가되었고, 2026년 97억 달러에서 2033년에는 164억 달러로 확대되어 2026-2033년 연평균 성장률(CAGR) 7.8%를 기록할 것으로 예측됩니다.
북미가 시장을 주도하고 있으며, 2025년 매출 점유율은 35.0%를 차지했습니다. 첨단 안과 기술에는 안과 의료의 정확성과 유효성을 향상시키는 영상 진단, 수술 기구, 레이저 시스템 및 생명공학의 발전 등이 포함됩니다. 고령 인구 증가, 안과 질환 유병률 상승, 기술 발전, 최소 침습 수술에 대한 수요 증가 등의 요인이 시장 성장을 크게 뒷받침하고 있습니다.
유형별로는 진단 부문이 시장을 주도하여, 2025년에는 약 55.0%의 점유율을 차지했습니다.
용도별로는 병원 부문이 시장을 주도하여 2025년에는 약 40.0%의 점유율을 차지했습니다.
2025년, 백내장, 녹내장, 당뇨성 망막병증, 근시 등의 안과 질환 유병률이 증가하고 있어, 첨단 안과 의료기기 시장은 급성장하고 있습니다. 예방적 진단 및 혁신적인 수술 기술에 대한 인식이 높아지면서 이러한 급속한 성장을 더욱 뒷받침하고 있습니다. 이 성장을 이끄는 주요 요인으로는 정밀한 안과 의료, 최소 침습 레이저 수술로의 전환, AI를 활용한 진단 등이 꼽히며, 이 모든 요소는 치료 성과를 대폭 향상시키고 세계적인 인지도를 높이고 있습니다.
백내장은 현재 노화에 따른 안과 질환 중 가장 흔한 것으로, 세계에서 매년 2,000만 건 이상의 수술이 이루어지고 있으며, 인구 고령화에 따라 이 수치는 더욱 증가할 것으로 예측됩니다. 또한, 안과 관련 단체의 추산에 따르면 세계적으로 10억 명 이상이 치료 가능하거나 예방 가능한 시력 장애로 고통받고 있어, 안과 분야에서 충족되지 않은 임상적 수요가 매우 크다는 사실이 부각되고 있습니다.
근시의 유병률 상승을 고려할 때, 2050년까지 세계 인구의 50% 가까이가 근시가 될 가능성이 있는 것으로 예측됩니다. 교정 기술 및 진단법에 대한 이러한 수요 증가는 향후 몇 년간 시장 성장을 견인할 것으로 전망됩니다.
자주 묻는 질문
목차
제1장 조사 방법 및 범위
제2장 요약
제3장 선진 안과 의료 기술 시장 : 변수, 동향, 범위
- 시장 개요 및 향후 전망
- 시장 규모 및 성장 전망
- 시장 역학
- 첨단 안과 의료 기술 시장 분석 도구
제4장 첨단 안과 의료 기술 시장 : 유형별 추정 및 동향 분석
- 첨단 안과 의료 기술 시장 : 유형별 동향 분석, 2025년&2033년
- 진단
- 치료
제5장 첨단 안과 의료 기술 시장 : 최종 용도별 추정 및 동향 분석
- 첨단 안과 의료 기술 시장 : 최종 용도별 동향 분석, 2025년&2033년
- 병원
- 외래수술센터(ASC)
- 안과 클리닉
제6장 첨단 안과 의료 기술 시장 : 지역별 추정 및 동향 분석
- 첨단 안과 의료 기술 시장 지역별 점유율, 2025년-2033년
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
- 아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
- 라틴아메리카
- 브라질
- 아르헨티나
- 중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트
제7장 경쟁 현황
- 주요 시장 진출기업들의 최근 동향 및 영향 분석
- 기업 분류
- 기업 히트맵 분석
- 기업 프로파일
- Carl Zeiss Meditec AG
- Bausch+Lomb.
- Teva Pharmaceutical Industries Ltd.
- CooperVision
- Alcon
- NIDEK CO., LTD.
- TOPCON CORPORATION
- Ziemer Ophthalmic Systems AG
- Essilor International S.A.
The global advanced ophthalmology technology market size was valued at USD 9.1 billion in 2025 and is projected to grow from USD 9.7 billion in 2026 to USD 16.4 billion in 2033, at a CAGR of 7.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.0% in 2025. Advanced ophthalmology technologies include imaging, surgical instruments, laser systems, and biotechnology advances that improve the accuracy and effectiveness of ophthalmic care. Factors such as the growing geriatric population, rising rates of eye-related disorders, technological advancements, and the need for minimally invasive procedures are significantly driving market growth.
By type, the diagnostics segment dominated the market and accounted for a share of around 55.0% in 2025.
By end use, the hospitals segment dominated the market and accounted for a share of around 40.0% in 2025.
The market for advanced ophthalmology devices is booming in 2025 due to the increasing prevalence of eye-related conditions such as cataracts, glaucoma, diabetic retinopathy, and myopia. A growing awareness of preventive diagnostics and innovative surgical techniques further fuels this surge. Key factors driving this growth include precise eye care, a shift towards less invasive laser surgeries, and AI-supported diagnosis, all of which have significantly improved treatment outcomes and raised global awareness.
Cataracts are currently the most common age-related eye condition, with over 20 million surgeries performed each year globally, and this number is expected to rise as the population ages. Additionally, estimates from ophthalmic organizations indicate that more than a billion people worldwide suffer from curable or preventable vision impairment, highlighting the substantial unmet clinical demand in the field of ophthalmology.
Considering the rising prevalence of myopia, it's projected that nearly 50 percent of the global population could be myopic by 2050. This growing demand for corrective technologies and diagnostic methods is likely to drive market growth in the coming years.
Advanced Ophthalmology Technology Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global advanced ophthalmology technology market report based on type, end use, and region.
- Type Outlook (Revenue, USD Billion, 2021 - 2033)
Diagnostic
Therapeutic
- End Use Outlook (Revenue, USD Billion, 2021 - 2033)
Hospitals
Ambulatory Surgical Centers (ASCs)
Ophthalmic Clinics
Others
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Advanced Ophthalmology Technology Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Advanced Ophthalmology Technology Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
- 3.4.1. Porter's Analysis
Chapter 4. Advanced Ophthalmology Technology Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Advanced Ophthalmology Technology Market: Type Movement Analysis, 2025 & 2033 (USD Million)
- 4.3. Diagnostic
- 4.3.1. Diagnostic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4. Therapeutic
- 4.4.1. Therapeutic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Advanced Ophthalmology Technology Market: End Use Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Advanced Ophthalmology Technology Market: End Use Movement Analysis, USD Million, 2025 & 2033
- 5.3. Hospitals
- 5.3.1. Hospital Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4. Ambulatory Surgical Centers
- 5.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Ophthalmic Clinics
- 5.5.1. Ophthalmic Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Advanced Ophthalmology Technology Market: Regional Estimates & Trend Analysis
- 6.1. Advanced Ophthalmology Technology Market Share, By Region, 2025 & 2033 (USD Million)
- 6.2. North America
- 6.2.1. North America Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.2.2. U.S.
- 6.2.2.1. U.S. Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.2.3. Canada
- 6.2.3.1. Canada Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.2.4. Mexico
- 6.2.4.1. Mexico Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3. Europe
- 6.3.1. Europe Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.2. UK
- 6.3.2.1. UK Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.3. Germany
- 6.3.3.1. Germany Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.4. France
- 6.3.4.1. France Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.5. Italy
- 6.3.5.1. Italy Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.6. Spain
- 6.3.6.1. Spain Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.7. Denmark
- 6.3.7.1. Denmark Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.8. Sweden
- 6.3.8.1. Sweden Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.9. Norway
- 6.3.9.1. Norway Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.2. Japan
- 6.4.2.1. Japan Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.3. China
- 6.4.3.1. China Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.4. India
- 6.4.4.1. India Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.5. Australia
- 6.4.5.1. Australia Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.6. South Korea
- 6.4.6.1. South Korea Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.7. Thailand
- 6.4.7.1. Thailand Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Latin America
- 6.5.1. Latin America Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.2. Brazil
- 6.5.2.1. Brazil Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3. Argentina
- 6.5.3.1. Argentina Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Middle East and Africa
- 6.6.1. Middle East and Africa Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.2. South Africa
- 6.6.2.1. South Africa Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.3. Saudi Arabia
- 6.6.3.1. Saudi Arabia Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.4. UAE
- 6.6.4.1. UAE Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.5. Kuwait
- 6.6.5.1. Kuwait Advanced Ophthalmology Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis by Key Market Participants
- 7.2. Company Categorization
- 7.3. Company Heat Map Analysis
- 7.4. Company Profiles
- 7.4.1. Carl Zeiss Meditec AG
- 7.4.1.1. Participant's Overview
- 7.4.1.2. Financial Performance
- 7.4.1.3. Product Benchmarking
- 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. Bausch + Lomb.
- 7.4.2.1. Participant's Overview
- 7.4.2.2. Financial Performance
- 7.4.2.3. Product Benchmarking
- 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Teva Pharmaceutical Industries Ltd.
- 7.4.3.1. Participant's Overview
- 7.4.3.2. Financial Performance
- 7.4.3.3. Product Benchmarking
- 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. CooperVision
- 7.4.4.1. Participant's Overview
- 7.4.4.2. Financial Performance
- 7.4.4.3. Product Benchmarking
- 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. Alcon
- 7.4.5.1. Participant's Overview
- 7.4.5.2. Financial Performance
- 7.4.5.3. Product Benchmarking
- 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. NIDEK CO., LTD.
- 7.4.6.1. Participant's Overview
- 7.4.6.2. Financial Performance
- 7.4.6.3. Product Benchmarking
- 7.4.6.4. Recent Developments/ Strategic Initiatives
- 7.4.7. TOPCON CORPORATION
- 7.4.7.1. Participant's Overview
- 7.4.7.2. Financial Performance
- 7.4.7.3. Product Benchmarking
- 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. Ziemer Ophthalmic Systems AG
- 7.4.8.1. Participant's Overview
- 7.4.8.2. Financial Performance
- 7.4.8.3. Product Benchmarking
- 7.4.8.4. Recent Developments/ Strategic Initiatives
- 7.4.9. Essilor International S.A.
- 7.4.9.1. Participant's Overview
- 7.4.9.2. Financial Performance
- 7.4.9.3. Product Benchmarking
- 7.4.9.4. Recent Developments/ Strategic Initiatives
- 7.4.1. Carl Zeiss Meditec AG
